Gene · 1075
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Whole genome sequencing and analysis of familial nonsyndromic congenital tooth agenesis]. | Hua Xi Kou Qiang Yi Xue Za Zhi | 2026 | 41919540 | PubTator, text mining | PubMed |
| A Compound Heterozygous Cathepsin C Mutations Causing Phenotypical Papillion Lafevre/Haim-Munk Syndrome: A Case Report and Review of WES Findings. | Spec Care Dentist | 2026 | 41914522 | PubTator, text mining | PubMed |
| Treatment of Lung Disease in Primary Ciliary Dyskinesia: A Review of Current and Emerging Interventions. | Pediatr Pulmonol | 2026 | 41889168 | PubTator, text mining | PubMed |
| CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2026 | 41881460 | PubTator, text mining | PubMed |
| FGFR signaling establishes spatial gradients of secretory cell identities along the airway proximal-distal axis. | Nat Commun | 2026 | 41851103 | PubTator, text mining | PubMed |
| Predicting clinical remission in biologic-treated severe asthma: development of a practical scoring system from a Japanese multicentre study. | BMJ Open Respir Res | 2026 | 41850735 | PubTator, text mining | PubMed |
| Ten unanswered questions about dipeptidyl peptidase-1 inhibition in bronchiectasis. | Lancet Respir Med | 2026 | 41839192 | PubTator, text mining | PubMed |
| Inhibition of Airway Epithelial CTSC Attenuates Type 2 Inflammation: Implications for Eosinophilic Chronic Rhinosinusitis with Nasal Polyps. | J Inflamm Res | 2026 | 41835123 | PubTator, text mining | PubMed |
| Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer. | J Immunother Cancer | 2026 | 41825935 | PubTator, text mining | PubMed |
| [Annual progress in the clinical management and research of bronchiectasis 2025]. | Zhonghua Jie He He Hu Xi Za Zhi | 2026 | 41820045 | PubTator, text mining | PubMed |
Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network. | ERJ Open Res | 2026 | 41809869 | PubTator, text mining | PubMed |
| Therapies for bronchiectasis: mechanisms and potential effects. | Front Immunol | 2026 | 41789076 | PubTator, text mining | PubMed |
| Proteolytic dysregulation in the skin: insight from rare monogenic skin diseases. | Cell Tissue Res | 2026 | 41776113 | PubTator, text mining | PubMed |
| Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review. | Br J Pharmacol | 2026 | 41771767 | PubTator, text mining | PubMed |
| Pediatric in-hospital life-threatening emergencies and cardiac arrest in France: adherence to international guidelines and barriers to implementation. | Resusc Plus | 2026 | 41767210 | PubTator, text mining | PubMed |
| Developing an Empirical Theory of Planned Behavior Model of Healthy Dietary Choice and Evaluating Gamified Feedback Among Japanese Young Adults. | Nutrients | 2026 | 41754203 | PubTator, text mining | PubMed |
| Targeting Neutrophil Function as Therapy for Hidradenitis Suppurativa. | Int J Mol Sci | 2026 | 41752212 | PubTator, text mining | PubMed |
| From GWAS Signals to Causal Genes in Chronic Kidney Disease. | Curr Issues Mol Biol | 2026 | 41751412 | PubTator, text mining | PubMed |
| Lipid Metabolism Reprogramming in Diffuse Large B-Cell Lymphoma (DLBCL): Mechanisms and Treatment Strategies. | Cancers (Basel) | 2026 | 41749954 | PubTator, text mining | PubMed |
| Uremic Toxin-Driven Vascular Calcification in Chronic Kidney Disease: Molecular Pathways and Integrated Phenotypes. | Toxins (Basel) | 2026 | 41745778 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/papers?page=3